1. BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension. (7th April 2022) Authors: Spikes, Leslie A.; Bajwa, Abubakr A.; Burger, Charles D.; Desai, Sapna V.; Eggert, Michael S.; El‐Kersh, Karim A.; Fisher, Micah R.; Johri, Shilpa; Joly, Joanna M.; Mehta, Jinesh; Palevsky, Harold I.; Ramani, Gautam V.; Restrepo‐Jaramillo, Ricardo; Sahay, Sandeep; Shah, Trushil G.; Deng, Chunqin;... Journal: Pulmonary circulation Issue: Volume 12:Number 2(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗